CAS: 73384-59-5; Ceftriaxone

该化合物是第三代甲状腺素抗生素,其抗药性广泛,对克菌阳性细菌和克菌阴性细菌具有广泛影响,其主要优点包括抗β-乳腺炎高度稳定,延长半衰期,允许一至两日服用一次或两次,以及良好的组织渗透,包括脑脊髓灰质素.氯丙烯酮对肺炎,流感嗜血杆菌,尼塞里亚脑膜炎和内肠杆菌病等病原体具有有效功效.它通常用于脑膜炎,败血症和复杂的尿道或呼吸道感染等严重感染,通过静脉注射或肌肉内感染,并配有可靠的药性肿瘤和有利的安全特征.它的双排卵道(肾脏和卵巢道)降低了肾损伤的剂量调整要求,提高了临床效用.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号79232-67-0 7-[4-bromo-2(Z)... | CAS号614751-38-1 (6R,7R)-7-((Z)-... | CAS号58909-39-0 三嗪环 | CAS号74578-69-1 头孢曲松钠

合成工艺路线路线简述

  • 合成目标产物 Ceftriaxone 主要起始原料 (6R-Trans)-7-Amino-8-Oxo-3-[[(1,2,5,6-Tetrahydro-2-Methyl-5,6-Dioxo-1,2,4-Triazin-3-yl)Thio]Methyl]-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid And S-2-Benzothiazolyl 2-Amino-Alpha-(Methoxyimino)-4-Thiazolethiolacetate
  • (文献来源)合成步骤主要原料 (6R-Trans)-7-Amino-8-Oxo-3-[[(1,2,5,6-Tetrahydro-2-Methyl-5,6-Dioxo-1,2,4-Triazin-3-yl)Thio]Methyl]-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid 和 S-2-Benzothiazolyl 2-Amino-Alpha-(Methoxyimino)-4-Thiazolethiolacetate

海关参考信息

专利信息


专利号:US-5847150-A
优先权日:1996-04-24
标题 :Solid phase and combinatorial synthesis of substituted 2-methylene-2, 3-dihydrothiazoles and of arrays of substituted 2-methylene-2, 3-dihydrothiazoles
发明人:DORWALD FLORENCIO ZARAGOZA
权利人:NOVO NORDISK AS
摘要:A solid phase method for the synthesis of a plurality of differently substituted 2-methylenethiazoles with a wide variety of side-chain substituents as compounds of potential therapeutic interest. The 2-methylenethiazoles are prepared by acylation of a substrate-bound primary or secondary amine with cyanoacetic acid and reaction of the resulting cyanoacetamide with an isothiocyanate in the presence of a base. Alkylation with an appropriate alkyl halide under acidic conditions yields differently substituted, support-bound 2-methylene-2,3-dihydrothiazoles. These may be screened on the substrate or cleaved from the substrate and then screened in solution. The efficient synthesis of a wide variety of 2-methylenethiazoles using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiazole-based libraries. The method disclosed here provides an easy and fast access to highly diverse heterocyclic compounds of therapeutic interest, amenable to automatization.

专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:US-2024197774-A1
优先权日:2021-04-16
标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
权利人:UNIV TEXAS
摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.

专利号:US-11744867-B2
优先权日:2017-02-14
标 题 :Modulation of microbial synthesis of 4-ethylphenol and 4-ethylphenyl sulfate in behavior and disease
发明人:NEEDHAM BRITTANY D; MAZMANIAN SARKIS K; SHARON GIL; FUNABASHI MASANORI; FISCHBACH MICHAEL A; HSIAO ELAINE Y; PATTERSON PAUL H
权利人:CALIFORNIA INST OF TECHN; UNIV CALIFORNIA
摘要:Some embodiments relate to genetically engineered bacterial strains for modulation of levels of the bacterial metabolite 4-ethylphenol (4EP) and its sulfated form, 4-ethylphenyl sulfate (4EPS). In some embodiments, the bacteria reduce or inhibit production of 4EP or 4EPS in the gut of a subject. The bacteria can ameliorate, delay the onset, or reduce the likelihood of one or more symptoms associated with anxiety and/or autism spectrum disorder (ASD) in the subject.

专利号:US-2005186197-A1
优先权日:2002-08-29
标 题:Peptide inhibitors of beta lactamases
发明人:PALZKILL TIMOTHY; HUANG WANZHI
摘要:Peptide inhibitors of β-lactamases have been identified by the synthesis of peptide arrays using synthesis SPOT technology. These peptide inhibitors of β-lactamase have activity against a broad spectrum of β-lactamases and are useful in a variety of applications.

专利号:US-8557979-B2
优先权日:2004-06-10
标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
发明人:CHOI WOO-BAEG; KOWALIK EWA
权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.
石家庄拓芬生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.tuofenshengwu.com
企业联系电话:15032713787👤
📞石家庄拓芬生物科技有限公司 ⚠️参考联系方式
联系人:刘总
电话:15032713787
手机:15032713787
传真:0953-5527128
邮箱:331212767@qq.com
通信地址: 河北省石家庄市晋州市桃工业区
邮编: 052260
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:河北省石家庄市晋州市桃工业区
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Gupta AK, Wadhwa A, Anand NK. Ceftriaxone. Indian Pediatr. 1990 Apr;27(4):381-4. 7(8):e016273. doi: 10.1136/bmjopen-2017-016273.
3: Zelenitsky SA, Beahm NP, Iacovides H, Ariano RE, Zhanel G. Limitations of ceftriaxone compared with cefazolin against MSSA: an integrated pharmacodynamic analysis. J Antimicrob Chemother. 2018 Jul 1;73(7):1888-1894. doi: 10.1093/jac/dky120. 17(7):501-510. doi: 10.1080/14787210.2019.1627872. Epub 2019 Jun 10. 62(7):1041-89. doi: 10.2165/00003495-200262070-00005. 25(2):e281-e282. doi: 10.1097/MJT.0000000000000540. 80(3):525-33. doi: 10.1111/bcp.12636. Epub 2015 Jun 11.
8: da Trindade MT, Salgado HRN. A Critical Review of Analytical Methods for Determination of Ceftriaxone Sodium. Crit Rev Anal Chem. 2018 Mar 4;48(2):95-101. doi: 10.1080/10408347.2017.1398063. Epub 2018 Jan 29. 17(17):1584-1587. doi: 10.2174/1389557516666160801092713. 1862(6):1317-1326. doi: 10.1016/j.bbagen.2018.02.014. Epub 2018 Mar 7.

合成参考文献


参考文献:10.1001/archoto.2009.218-a
摘要:Hitier M, Boutet C, Faure C, Abadie C, Moreau S. Radiology quiz case 2. Gradenigo syndrome caused by right petrous apicitis. Arch Otolaryngol Head Neck Surg. 2010 Feb;136(2):201; 203. doi: 10.1001/archoto.2009.218-a.
参考文献:10.1016/j.pediatrneurol.2009.11.004
摘要:Farooque P, Khurana DS, Melvin JJ. Persistent focal seizures after cat scratch encephalopathy. Pediatr Neurol. 2010 Mar;42(3):215–8. doi: 10.1016/j.pediatrneurol.2009.11.004.
参考文献:10.1007/s10895-011-0917-0
摘要:Shah J, Jan MR, Shah S, Naeem M. Spectrofluorimetric protocol for ceftriaxone in commercial formulation and human plasma after condensation with formaldehyde and ethyl acetoacetate. J Fluoresc. 2011 Nov;21(6):2155–63. doi: 10.1007/s10895-011-0917-0.
参考文献:10.3201/eid/1706.101949|10.3201/eid1706.101949
摘要:Su LH, Teng WS, Chen CL, Lee HY, Li HC, Wu TL, Chiu CH. Increasing ceftriaxone resistance in Salmonellae, Taiwan. Emerg Infect Dis. 2011 Jun;17(6):1086–90.
参考文献:10.1016/j.jcis.2011.06.039
摘要:Luo Z, Wu Q, Zhang M, Li P, Ding Y. Cooperative antimicrobial activity of CdTe quantum dots with rocephin and fluorescence monitoring for Escherichia coli. J Colloid Interface Sci. 2011 Oct 01;362(1):100–6. doi: 10.1016/j.jcis.2011.06.039.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知